Published in J Pediatr Gastroenterol Nutr on June 01, 2012
Best strategies for global HCV eradication. Liver Int (2013) 1.16
KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol (2016) 1.15
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016. J Clin Exp Hepatol (2016) 1.02
KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol (2014) 0.99
Burden of pediatric hepatitis C. World J Gastroenterol (2013) 0.93
Pathogenesis of hepatitis C during pregnancy and childhood. Viruses (2012) 0.90
Hepatitis C virus: Virology, diagnosis and treatment. World J Hepatol (2015) 0.89
Vertical transmission of hepatitis C virus: Current knowledge and perspectives. World J Hepatol (2014) 0.89
Vertical hepatitis C virus transmission: Main questions and answers. World J Hepatol (2014) 0.85
Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World J Gastroenterol (2016) 0.83
Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression. World J Gastroenterol (2016) 0.79
New prospects for the treatment and prevention of hepatitis C in children. Curr Opin Pediatr (2016) 0.79
Hepatitis C Viral Infection in Children: Updated Review. Pediatr Gastroenterol Hepatol Nutr (2016) 0.79
What's new in hepatitis C virus infections in children? World J Gastroenterol (2015) 0.78
Cirrhosis in children and adolescents: An overview. World J Hepatol (2015) 0.78
Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children. World J Gastroenterol (2014) 0.78
New treatments for chronic hepatitis C: an overview for paediatricians. World J Gastroenterol (2014) 0.77
Hepatitis C Virus in Pregnancy and Early Childhood: Current Understanding and Knowledge Deficits. J Pediatric Infect Dis Soc (2014) 0.76
State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization. J Immunol Res (2016) 0.75
Hepatitis B and C. Pediatr Clin North Am (2017) 0.75
Chronic Hepatitis C Infection in Children: Current Treatment and New Therapies. J Clin Transl Hepatol (2015) 0.75
Single Clinical Practice's Report of Testing Initiation, Antibody Clearance, and Transmission of Hepatitis C Virus (HCV) in Infants of Chronically HCV-Infected Mothers. Open Forum Infect Dis (2016) 0.75
Hepatitis C in the pediatric population: transmission, natural history, treatment and liver transplantation. World J Gastroenterol (2014) 0.75
HCV treatment in children and young adults with HIV/HCV co-infection in Europe. J Virus Erad (2015) 0.75
CD4(+) and CD8(+) T Cell Activation in Children with Hepatitis C. J Pediatr (2015) 0.75
Treating hepatitis C virus in children: time for a new paradigm. J Virus Erad (2015) 0.75
The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C. J Clin Transl Hepatol (2017) 0.75
Hepatitis C: Review of the Epidemiology, Clinical Care, and Continued Challenges in the Direct Acting Antiviral Era. Curr Epidemiol Rep (2017) 0.75
Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med (2002) 3.91
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA (2011) 3.37
A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr (2006) 3.32
Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr (2006) 3.03
The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C. Gastroenterology (2010) 2.48
Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists. J Pediatr (2005) 2.15
Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure. Pediatr Crit Care Med (2012) 2.13
Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J Clin Invest (2013) 2.04
Portopulmonary hypertension in pediatric patients. J Pediatr (2005) 2.03
Baseline Analysis of a Young α-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension. J Pediatr Gastroenterol Nutr (2015) 1.98
Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial. Hepatology (2008) 1.85
Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. J Pediatr Gastroenterol Nutr (2012) 1.82
Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr (2003) 1.80
Extrahepatic anomalies in infants with biliary atresia: results of a large prospective North American multicenter study. Hepatology (2013) 1.80
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg (2004) 1.79
Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology (2013) 1.78
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr (2007) 1.74
North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr (2008) 1.72
Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium. Hepatology (2007) 1.68
Primary liver carcinoma arising in people younger than 30 years. Am J Clin Pathol (2005) 1.66
Controversies in the management of pediatric liver disease: Hepatitis B, C and NAFLD: Summary of a single topic conference. Hepatology (2006) 1.64
Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol (2010) 1.60
Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency. Gastroenterology (2013) 1.57
Pediatric liver transplantation for urea cycle disorders and organic acidemias: United Network for Organ Sharing data for 2002-2012. Liver Transpl (2013) 1.52
Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. Contemp Clin Trials (2009) 1.48
Biliary atresia: the Canadian experience. J Pediatr (2007) 1.46
Trends over a decade of pediatric liver transplantation in the United States. Liver Transpl (2006) 1.45
Abnormalities in villin gene expression and canalicular microvillus structure in progressive cholestatic liver disease of childhood. Lancet (2003) 1.41
Growth hormone therapy improves growth in children with cystic fibrosis related liver disease. J Pediatr Endocrinol Metab (2008) 1.40
More lessons from the Taiwanese hepatitis B virus vaccine program. J Infect Dis (2012) 1.37
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA (2012) 1.33
Niemann-pick disease type C in neonatal cholestasis at a North American Center. J Pediatr Gastroenterol Nutr (2002) 1.25
Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C. J Pediatr Gastroenterol Nutr (2009) 1.25
Hedgehog activity, epithelial-mesenchymal transitions, and biliary dysmorphogenesis in biliary atresia. Hepatology (2011) 1.22
Characterization of acute liver failure and development of a continuous risk of death staging system in children. J Hepatol (2005) 1.20
Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology (2010) 1.19
Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Am J Gastroenterol (2010) 1.17
Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40 kd) in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr (2006) 1.15
Delineating definitions and risk factors for metabolic syndrome after pediatric liver transplantation. Liver Transpl (2014) 1.07
Brain MR imaging in neonatal hyperammonemic encephalopathy resulting from proximal urea cycle disorders. AJNR Am J Neuroradiol (2003) 1.05
An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr (2002) 1.05
Epidemiology of primary hepatic malignancies in U.S. children. Hepatology (2003) 1.04
Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic hepatitis C viral infection. Clin Trials (2007) 1.03
Current issues in the management of paediatric viral hepatitis. Liver Int (2009) 1.03
Maternal microchimerism in the livers of patients with biliary atresia. BMC Gastroenterol (2004) 1.03
Portal hypertension in children and young adults with biliary atresia. J Pediatr Gastroenterol Nutr (2012) 1.01
Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial. Hepatology (2012) 1.01
Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes. J Pediatr Gastroenterol Nutr (2009) 1.01
The seroprevalence of Helicobacter pylori in a referral population of children in the United States. Am J Gastroenterol (2003) 1.01
Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia. Pediatrics (2012) 1.00
Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology (2006) 0.99
Spontaneous perforation of the bile duct in a toddler: the role of endoscopic retrograde cholangiopancreatography in diagnosis and therapy. J Pediatr Gastroenterol Nutr (2006) 0.99
Characterization and outcomes of young infants with acute liver failure. J Pediatr (2011) 0.98
Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication. Antiviral Res (2002) 0.97
Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort. PLoS One (2012) 0.97
Outcome after percutaneous endoscopic gastrostomy in children and young adults. J Pediatr Gastroenterol Nutr (2010) 0.96
Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children. Hepatology (2011) 0.95
Recommendations for screening, monitoring, and referral of pediatric chronic hepatitis B. Pediatrics (2009) 0.95
Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C. J Pediatr Gastroenterol Nutr (2013) 0.94
Alagille syndrome and liver transplantation. J Pediatr Gastroenterol Nutr (2010) 0.93
Interpreting conjugated bilirubin levels in newborns. J Pediatr (2010) 0.93
Laparoscopic suture rectopexy for full-thickness anorectal prolapse in children: an effective outpatient procedure. J Pediatr Surg (2010) 0.92
Hepatic failure and liver transplant: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr (2004) 0.92
Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon. J Pediatr Gastroenterol Nutr (2010) 0.92
Biliary atresia with associated structural malformations in Canadian infants. Liver Int (2011) 0.92
NASPGHAN guidelines for training in pediatric gastroenterology. J Pediatr Gastroenterol Nutr (2013) 0.91
Malnutrition: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr (2004) 0.91
Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure. Clin Gastroenterol Hepatol (2008) 0.91
Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database. J Med Chem (2004) 0.91
Managing pediatric hepatitis C: current and emerging treatment options. Ther Clin Risk Manag (2009) 0.90
Biliary atresia in Canada: the effect of centre caseload experience on outcome. J Pediatr Gastroenterol Nutr (2010) 0.90
Derivation of a clinical prediction rule for the noninvasive diagnosis of varices in children. J Pediatr Gastroenterol Nutr (2010) 0.89
Children Treated With Pegylated Interferon alfa-2a ± Ribavirin for Chronic Hepatitis C. J Pediatr Gastroenterol Nutr (2016) 0.89
Prevalence of vitamin K deficiency in children with mild to moderate chronic liver disease. J Pediatr Gastroenterol Nutr (2006) 0.88
Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study. Hepatology (2013) 0.88